Related Experiment Video
Updated: Jul 23, 2025

Intracerebroventricular Treatment with Resiniferatoxin and Pain Tests in Mice
Published on: September 2, 2020
Antihyperalgesic effect of joint mobilization requires Cav3.2 calcium channels
Daniel F Martins1,2, Victor Sorrentino1, Leidiane Mazzardo-Martins1,2
1Experimental Neuroscience Laboratory (LaNEx), Postgraduate Program in Health Sciences, University of Southern Santa Catarina, Palhoça, SC, Brazil.
Abstract:
The present study was undertaken to explore the relative contributions of Cav3.2 T-type channels to mediating the antihyperalgesic activity of joint manipulation (JM) therapy. We used the chronic constriction injury model (CCI) to induce peripheral neuropathy and chronic pain in male mice, followed by JM. We demonstrate that JM produces long-lasting mechanical anti-hyperalgesia that is abolished in Cav3.2 null mice. Moreover, we found that JM displays a similar analgesic profile as the fatty acid amide hydrolase inhibitor URB597, suggesting a possible converging mechanism of action involving endocannabinoids. Overall, our findings advance our understanding of the mechanisms through which JM produces analgesia.
Insights
Joint manipulation (JM) therapy alleviates chronic pain by targeting Cav3.2 T-type channels. This therapy
Area of Science:
- Neuroscience
- Pain Research
- Pharmacology
Background:
- Peripheral neuropathy and chronic pain are significant challenges.
- Joint manipulation (JM) therapy shows promise for pain relief.
- The precise mechanisms underlying JM's analgesic effects require elucidation.
Purpose of the Study:
- To investigate the role of Cav3.2 T-type channels in mediating the antihyperalgesic effects of JM therapy.
- To explore potential converging mechanisms involving endocannabinoids.
Main Methods:
- Utilized the chronic constriction injury (CCI) mouse model to induce peripheral neuropathy.
- Administered JM therapy to mice with induced chronic pain.
- Assessed mechanical antihyperalgesia in wild-type and Cav3.2 null mice.
- Compared JM's analgesic profile with the fatty acid amide hydrolase inhibitor URB597.
Main Results:
- JM therapy produced long-lasting mechanical antihyperalgesia in mice.
- The antihyperalgesic effect of JM was completely abolished in Cav3.2 null mice.
- JM exhibited an analgesic profile similar to URB597, suggesting a role for endocannabinoids.
Conclusions:
- Cav3.2 T-type channels are essential for the antihyperalgesic activity of JM therapy.
- JM therapy may act through a mechanism involving endocannabinoids.
- These findings enhance the understanding of JM's pain-relieving mechanisms.
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Analgesia and Pain Management
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Nociception
Antihypertensive Drugs: Action of Calcium Channel Blockers
Local Anesthetics: Mechanism of Action
Local anesthetics are amphiphilic molecules consisting of a hydrophobic aromatic part linked to a hydrophilic group by an ester or amide linkage. They are weak bases and are usually available as salts, which increases their solubility and stability. Once administered, LAs exist in the body either...

